HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
106.000 |
Evidence |
|
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
TAL1 |
TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 |
106.000 |
Evidence |
|
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
106.000 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
106.000 |
Evidence |
|
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
106.000 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
106.000 |
Evidence |
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
106.000 |
Evidence |
O
|
GTF2A2 |
GTF2A2, TF2A2: Transcription initiation factor IIA gamma chain |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
106.000 |
Evidence |
|
POLR2D |
POLR2D: DNA-directed RNA polymerase II subunit RPB4 |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
106.000 |
Evidence |
O
|
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
PDHB |
IPI00549885 |
106.000 |
Evidence |
|
PDHA1 |
PDHA1, PHE1A: Pyruvate dehydrogenase E1 component subunit alpha, somatic form, m |
DLAT |
Dihydrolipoamide S-acetyltransferase (Fragment) |
106.000 |
Evidence |
O
|
CSNK2A2 |
CSNK2A2, CK2A2: Casein kinase II subunit alpha' |
CGI-48 |
UTP18, WDR50, CDABP0061, CGI-48: U3 small nucleolar RNA-associated protein 18 ho |
106.000 |
Evidence |
|
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
106.000 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
SYK |
SYK: Tyrosine-protein kinase SYK |
105.000 |
Evidence |
|
SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
EIF4G2 |
EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 |
105.000 |
Evidence |
|
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
105.000 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
105.000 |
Evidence |
|
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
105.000 |
Evidence |
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
105.000 |
Evidence |
|
ORC1L |
ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 |
CCNB1 |
Cyclin B1 |
105.000 |
Evidence |
|
MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
ORC1L |
ORC1L, ORC1, PARC1: Origin recognition complex subunit 1 |
105.000 |
Evidence |
|
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CFL1 |
CFL1, CFL: Cofilin-1 |
105.000 |
Evidence |
O
|